8/8/2025Recent Executive Moves

8/8/2025Jingxin Gains Exclusive China Rights to Gedeon Richter's Schizophrenia...

8/8/2025Wuxi Apptec Strengthens European Foothold with Luxembourg Expansion Am...

8/8/2025​​​​​​​ExoNeuglia Raises Series A+ Funding to Advance iPSC Ther...

8/8/2025Fujian Haixi Pharma Files for Hong Kong IPO

8/8/2025Hengrui Launches Phase 3 Trial of Trastuzumab Rezetecan Combo for AGC

8/8/2025Boan's Dulaglutide Biosimilar Secures NMPA Approval in China

8/8/2025Triple Squeeze Threatens China's Global Drug Push

8/8/2025Shanghai Unveils 18 New Measures to Boost Commercial Health Insurance ...

8/8/2025Minghui Raises $131M to Accelerate Clinical and Commercial Expansion

8/8/2025Innogen Launches $87M Hong Kong IPO to Fund Trials and Launches

More>>

8/8/2025China Biopharma Tracker – July 2025: Funding Surges and Major Deals (...

8/8/2025Pharma MNCs in China H1/2025 – Mature Products Exit, Top Performers R...

8/7/2025Innovation through Talent: How Leadership Is Evolving in China's Life ...

8/6/2025Big Pharma Provides Lifeline to Chinese Companies Struggling To Surviv...

8/6/2025Novartis Heart Drug A China Case Study: How Drug Exclusivity Dies by a...

8/1/2025What the Latest Volume-Based Procurement Changes in China Mean for Pha...

7/31/2025China's Plan to Boost Drug Coverage by Commercial Insurers No 'Magic W...

7/29/2025US Drug Supply Chain Exposure to China (Brookings)

7/23/2025Accelerating US Oncology Drug Development Using Chinese First-in-Human...

7/22/2025PharmaDJ's China Biopharma Tracker – June 2025 (PharmaDJ)

7/12/2025Analysing Key Trends In China's Patent-linkage System and Their Impact...

More>>